The University of Kentucky Sanders-Brown Center on Aging (SBCoA) basic and clinical scientists work together to improve the health of the elderly in Kentucky and beyond through research dedicated to understanding the aging process and age-related brain diseases, and education, outreach and clinical programs that promote healthy brain aging.
An integral part of SBCoA is the National Institute on Aging-funded University of Kentucky Alzheimer's Disease Center (UK-ADC). Over the past 30 years, the UK-ADC has developed a vigorous program in the clinical, neuropathological, educational, and research aspects of Alzheimer's disease that serves as a critical resource for the university, community, state, and nation.
July 2016 — The UK-ADC was awarded an $8.25 million, five-year grant from the National Institutes of Health (NIH) to continue and further research and clinical initiatives geared toward treating Alzheimer's disease. Currently, only 30 designated Alzheimer's Disease Centers exist in the U.S. In 1985, Sanders-Brown was among the first 10 ADCs funded by the NIH and has been continuously funded since the designation was launched.
Another key research area of SBCoA is the Down Syndrome Aging & Alzheimer's Disease Study (UK-DSA). The goal of this research is to follow people with Down syndrome as they get older. This will help us to understand why and who will develop dementia. Importantly, if we follow people who do not develop dementia we may be able to learn how to prevent this from occurring in others.